Xue‐Mei You

1.6k total citations · 1 hit paper
42 papers, 1.1k citations indexed

About

Xue‐Mei You is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Xue‐Mei You has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 17 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Xue‐Mei You's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease Diagnosis and Treatment (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Xue‐Mei You is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease Diagnosis and Treatment (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Xue‐Mei You collaborates with scholars based in China, Italy and United States. Xue‐Mei You's co-authors include Jian‐Hong Zhong, Liang Ma, Bang‐De Xiang, Rong‐Rui Huo, Le‐Qun Li, Le‐Qun Li, Lu Zhai, Qian Liao, Yanyan Wang and Wen‐Feng Gong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xue‐Mei You

40 papers receiving 1.1k citations

Hit Papers

Interacting and joint effects of triglyceride-glucose ind... 2024 2026 2025 2024 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating role of TyG in middle-aged and older Chinese adults: a nationwide prospective cohort study
    2024 87 citations Rong‐Rui Huo, Qian Liao et al. Cardiovascular Diabetology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue‐Mei You China 20 485 421 197 196 167 42 1.1k
Marcus‐Alexander Wörns Germany 20 812 1.7× 680 1.6× 211 1.1× 145 0.7× 325 1.9× 74 1.3k
Maurizio Baldassarre Italy 21 478 1.0× 501 1.2× 386 2.0× 118 0.6× 190 1.1× 63 1.4k
Ayman Ibrahim United States 16 268 0.6× 238 0.6× 168 0.9× 169 0.9× 216 1.3× 22 839
A. Ruiz‐Extremera Spain 17 841 1.7× 901 2.1× 283 1.4× 197 1.0× 70 0.4× 65 1.6k
Müjdat Zeybel Türkiye 16 184 0.4× 490 1.2× 534 2.7× 52 0.3× 128 0.8× 33 1.2k
Xinyue Chen China 17 555 1.1× 683 1.6× 192 1.0× 54 0.3× 80 0.5× 132 1.1k
Fabrice Lainé France 26 534 1.1× 831 2.0× 106 0.5× 101 0.5× 170 1.0× 83 1.9k
Jialin Zhang China 15 157 0.3× 124 0.3× 128 0.6× 76 0.4× 259 1.6× 59 625

Countries citing papers authored by Xue‐Mei You

Since Specialization
Citations

This map shows the geographic impact of Xue‐Mei You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue‐Mei You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue‐Mei You more than expected).

Fields of papers citing papers by Xue‐Mei You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue‐Mei You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue‐Mei You. The network helps show where Xue‐Mei You may publish in the future.

Co-authorship network of co-authors of Xue‐Mei You

This figure shows the co-authorship network connecting the top 25 collaborators of Xue‐Mei You. A scholar is included among the top collaborators of Xue‐Mei You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue‐Mei You. Xue‐Mei You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huo, Rong‐Rui, et al.. (2024). Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating role of TyG in middle-aged and older Chinese adults: a nationwide prospective cohort study. Cardiovascular Diabetology. 23(1). 30–30. 87 indexed citations breakdown →
2.
Huo, Rong‐Rui, Lu Zhai, Qian Liao, & Xue‐Mei You. (2023). Changes in the triglyceride glucose-body mass index estimate the risk of stroke in middle-aged and older Chinese adults: a nationwide prospective cohort study. Cardiovascular Diabetology. 22(1). 254–254. 70 indexed citations
3.
Chen, Kang, K. Wang, Qin Luo, et al.. (2022). Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma. Frontiers in Oncology. 12. 946693–946693. 6 indexed citations
4.
Lin, Jing, et al.. (2020). Factors associated with resilience among non-local medical workers sent to Wuhan, China during the COVID-19 outbreak. BMC Psychiatry. 20(1). 417–417. 71 indexed citations
5.
Xiang, Xiao, Xue‐Mei You, & Le‐Qun Li. (2018). Expression of HSP90AA1/HSPA8 in hepatocellular carcinoma patients with depression. OncoTargets and Therapy. Volume 11. 3013–3023. 40 indexed citations
6.
Liao, Ying‐Yang, Xue‐Mei You, Alessandro Cucchetti, et al.. (2017). Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy. PLoS ONE. 12(3). e0174222–e0174222. 10 indexed citations
7.
Zhong, Jian‐Hong, Linghui Pan, Yanyan Wang, et al.. (2017). Optimizing stage of single large hepatocellular carcinoma. Medicine. 96(15). e6608–e6608. 13 indexed citations
8.
Wang, Yanyan, Jian‐Hong Zhong, Jiazhou Ye, et al.. (2017). High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma. Scientific Reports. 7(1). 42199–42199. 25 indexed citations
9.
Xiao, Xiang, et al.. (2017). Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma. Clinical & Translational Oncology. 19(7). 891–897. 20 indexed citations
10.
Wang, Yanyan, Ning‐Fu Peng, Yuchong Peng, et al.. (2016). Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma. Medicine. 95(5). e2722–e2722. 39 indexed citations
11.
Peng, Yuchong, Jian‐Hong Zhong, Zhibo Xie, et al.. (2016). Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activity. Tumor Biology. 37(8). 10943–10958. 4 indexed citations
12.
Luo, Tao, Jie Chen, Hang Li, et al.. (2016). Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis. OncoTargets and Therapy. Volume 9. 4483–4489. 2 indexed citations
13.
Zhong, Jian‐Hong, Yang Ke, Shao‐Liang Zhu, et al.. (2016). Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection. OncoTargets and Therapy. Volume 9. 6897–6907. 10 indexed citations
14.
Zhu, Shao‐Liang, Jian‐Hong Zhong, Yang Ke, et al.. (2015). Comparative efficacy of postoperative transarterial chemoembolization with or without antiviral therapy for hepatitis B virus-related hepatocellular carcinoma. Tumor Biology. 36(8). 6277–6284. 13 indexed citations
15.
Zhong, Jian‐Hong, Hang Li, Nan Xiao, et al.. (2014). Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension. PLoS ONE. 9(9). e108755–e108755. 43 indexed citations
16.
Gong, Wen‐Feng, Jian‐Hong Zhong, Bang‐De Xiang, et al.. (2013). Single Nucleotide Polymorphism 8q24 rs13281615 and Risk of Breast Cancer: Meta-Analysis of More than 100,000 Cases. PLoS ONE. 8(4). e60108–e60108. 13 indexed citations
17.
Ye, Jiazhou, Feixiang Wu, Zhao Yin-nong, Le‐Qun Li, & Xue‐Mei You. (2012). Recurrence after anatomic versus nonanatomic resection for hepatocellular carcinoma: a Meta-analysis. Zhonghua gan-dan waike zazhi. 18(8). 582–588.
18.
Zhong, Jian‐Hong, Xue‐Mei You, Wen‐Feng Gong, et al.. (2012). Epidermal Growth Factor Gene Polymorphism and Risk of Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE. 7(3). e32159–e32159. 45 indexed citations
19.
20.
Chen, Defeng, et al.. (2009). Evaluation the affect of psychological counseling intervention on the immune function in the preoperative anxiety patients with liver cancer. Zhonghua xiandai huli zazhi. 15(24). 2360–2364. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcus‐Alexander Wörns Breakdown of academic impact, for papers by Maurizio Baldassarre Breakdown of academic impact, for papers by Ayman Ibrahim Breakdown of academic impact, for papers by A. Ruiz‐Extremera Breakdown of academic impact, for papers by Müjdat Zeybel Breakdown of academic impact, for papers by Xinyue Chen Breakdown of academic impact, for papers by Fabrice Lainé Breakdown of academic impact, for papers by Jialin Zhang
Rankless by CCL
2026